ARTICLE | Company News
AMAG Pharmaceuticals, Silverstrand Investments hematology news
November 3, 2014 8:00 AM UTC
AMAG will pay $3.8 million to settle a class action lawsuit -- Silverstrand Investments, et al. v. AMAG Pharmaceuticals, et al. -- involving anemia drug Feraheme ferumoxytol. In February 2013, the Fi...